|

Guselkumab Clinical Trials

8 actively recruiting trials across 6 locations

Also known as: CNTO1959, TREMFYA, Tremfya

Other2 trials

A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)
Phase 4
Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.
Phase 4

Avondale, Arizona1 trial

A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease

Arizona Arthritis and Rheumatology Research PLLC

Phase 4

La Jolla, California1 trial

Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project

University of California, San Diego

San Diego, California1 trial

Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy

University of California, San Diego

N/A

Loxahatchee Groves, Florida1 trial

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients

Family Arthritis Center

Phase 3

Atlanta, Georgia1 trial

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

Emory University

Phase 3

Boston, Massachusetts1 trial

Multi-Center PAMPA Study

Brigham and Women's Hospital

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.